Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2018 (2018), Article ID 5201759, 9 pages
https://doi.org/10.1155/2018/5201759
Review Article

The Role of Phospholipase C Signaling in Macrophage-Mediated Inflammatory Response

1College of Veterinary Medicine and Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, 48 Wenhui East Road, Yangzhou, Jiangsu 225009, China
2Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, USA
3College of Animal Science and Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan 450002, China

Correspondence should be addressed to Clinton Jones; ude.etatsko@01senoj.tnilc and Gaiping Zhang; moc.361@3002gnipiaggnahz

Received 24 June 2017; Revised 6 October 2017; Accepted 5 November 2017; Published 8 February 2018

Academic Editor: Zissis Chroneos

Copyright © 2018 Liqian Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Ferrero-Miliani, O. H. Nielsen, P. S. Andersen, and S. E. Girardin, “Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation,” Clinical and Experimental Immunology, vol. 147, no. 2, pp. 227–235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Kaminska, “MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits,” Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics, vol. 1754, no. 1-2, pp. 253–262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Fujiwara and K. Kobayashi, “Macrophages in inflammation,” Current Drug Targets - Inflammation & Allergy, vol. 4, no. 3, pp. 281–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. S. Yi, Y. J. Son, C. Ryou, G. H. Sung, J. H. Kim, and J. Y. Cho, “Functional roles of Syk in macrophage-mediated inflammatory responses,” Mediators of Inflammation, vol. 2014, Article ID 270302, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Medzhitov, “Inflammation 2010: new adventures of an old flame,” Cell, vol. 140, no. 6, pp. 771–776, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Dunster, “The macrophage and its role in inflammation and tissue repair: mathematical and systems biology approaches,” Wiley Interdisciplinary Reviews Systems Biology and Medicine, vol. 8, no. 1, pp. 87–99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. N. J. Reyes, E. G. O'Koren, and D. R. Saban, “New insights into mononuclear phagocyte biology from the visual system,” Nature Reviews Immunology, vol. 17, no. 5, pp. 322–332, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, “Macrophage activation and polarization,” Frontiers in Bioscience, vol. 13, no. 13, pp. 453–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Wang, H. Liang, and K. Zen, “Molecular mechanisms that influence the macrophage M1-M2 polarization balance,” Frontiers in Immunology, vol. 5, p. 614, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Sindrilaru, T. Peters, S. Wieschalka et al., “An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice,” The Journal of Clinical Investigation, vol. 121, no. 3, pp. 985–997, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Fritz, R. L. Ferrero, D. J. Philpott, and S. E. Girardin, “Nod-like proteins in immunity, inflammation and disease,” Nature Immunology, vol. 7, no. 12, pp. 1250–1257, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. N. W. Palm and R. Medzhitov, “Pattern recognition receptors and control of adaptive immunity,” Immunological Reviews, vol. 227, no. 1, pp. 221–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Franken, M. Schiwon, and C. Kurts, “Macrophages: sentinels and regulators of the immune system,” Cellular Microbiology, vol. 18, no. 4, pp. 475–487, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. P. R. Taylor, L. Martinez-Pomares, M. Stacey, H. H. Lin, G. D. Brown, and S. Gordon, “Macrophage receptors and immune recognition,” Annual Review of Immunology, vol. 23, no. 1, pp. 901–944, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Gordon, A. Pluddemann, and F. Martinez Estrada, “Macrophage heterogeneity in tissues: phenotypic diversity and functions,” Immunological Reviews, vol. 262, no. 1, pp. 36–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Gordon, “Pattern recognition receptors: doubling up for the innate immune response,” Cell, vol. 111, no. 7, pp. 927–930, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Wadsworth, D. E. Cavender, S. A. Beers et al., “RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase,” The Journal of Pharmacology and Experimental Therapeutics, vol. 291, no. 2, pp. 680–687, 1999. View at Google Scholar
  18. J. W. Lee, N. H. Kim, J. Y. Kim et al., “Aromadendrin inhibits lipopolysaccharide-induced nuclear translocation of NF-ĸB and phosphorylation of JNK in RAW 264.7 macrophage cells,” Biomolecules & Therapeutics, vol. 21, pp. 216–221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Tisoncik, M. J. Korth, C. P. Simmons, J. Farrar, T. R. Martin, and M. G. Katze, “Into the eye of the cytokine storm,” Microbiology and Molecular Biology Reviews, vol. 76, no. 1, pp. 16–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. J. Lee and C. Lee, “Cytokine production in immortalized porcine alveolar macrophages infected with porcine reproductive and respiratory syndrome virus,” Veterinary Immunology and Immunopathology, vol. 150, no. 3-4, pp. 213–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Han, L. Zhou, X. Ge, X. Guo, and H. Yang, “Pathogenesis and control of the Chinese highly pathogenic porcine reproductive and respiratory syndrome virus,” Veterinary Microbiology, vol. 209, pp. 30–47, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. J. H. Beigel, J. Farrar, A. M. Han et al., “Avian influenza A (H5N1) infection in humans,” The New England Journal of Medicine, vol. 353, no. 13, pp. 1374–1385, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Peiris, K. P. Hui, and H. L. Yen, “Host response to influenza virus: protection versus immunopathology,” Current Opinion in Immunology, vol. 22, no. 4, pp. 475–481, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Liu, Y. H. Zhou, and Z. Q. Yang, “The cytokine storm of severe influenza and development of immunomodulatory therapy,” Cellular & Molecular Immunology, vol. 13, no. 1, pp. 3–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Hofmann, H. Sprenger, A. Kaufmann et al., “Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response,” Journal of Leukocyte Biology, vol. 61, no. 4, pp. 408–414, 1997. View at Google Scholar
  26. N. V. Serbina, T. Jia, T. M. Hohl, and E. G. Pamer, “Monocyte-mediated defense against microbial pathogens,” Annual Review of Immunology, vol. 26, no. 1, pp. 421–452, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Shi and E. G. Pamer, “Monocyte recruitment during infection and inflammation,” Nature Reviews Immunology, vol. 11, no. 11, pp. 762–774, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Hou, T. Kirchner, M. Singer, M. Matheis, D. Argentieri, and D. Cavender, “In vivo activity of a phospholipase C inhibitor, 1-(6-((17β-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions,” The Journal of Pharmacology and Experimental Therapeutics, vol. 309, no. 2, pp. 697–704, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Zhu, C. Yuan, Y. Ma, X. Ding, G. Zhu, and Q. Zhu, “Anti-inflammatory activities of phospholipase C inhibitor U73122: inhibition of monocyte-to-macrophage transformation and LPS-induced pro-inflammatory cytokine expression,” International Immunopharmacology, vol. 29, no. 2, pp. 622–627, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Zhu, C. Yuan, X. Ding et al., “PLC-γ1 is involved in the inflammatory response induced by influenza A virus H1N1 infection,” Virology, vol. 496, pp. 131–137, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Nakamura and K. Fukami, “Regulation and physiological functions of mammalian phospholipase C,” Journal of Biochemistry, vol. 161, no. 4, pp. 315–321, 2017. View at Publisher · View at Google Scholar
  32. W. D. Singer, H. A. Brown, and P. C. Sternweis, “Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D,” Annual Review of Biochemistry, vol. 66, no. 1, pp. 475–509, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Fukami, S. Inanobe, K. Kanemaru, and Y. Nakamura, “Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance,” Progress in Lipid Research, vol. 49, no. 4, pp. 429–437, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. C. H. Wilson, E. S. Ali, N. Scrimgeour et al., “Steatosis inhibits liver cell store-operated Ca2+ entry and reduces ER Ca2+ through a protein kinase C-dependent mechanism,” The Biochemical Journal, vol. 466, no. 2, pp. 379–390, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. G. G. Wescott, C. M. Manring, and D. M. Terrian, “Translocation assays of protein kinase C activation,” Methods in Molecular Medicine, vol. 22, pp. 125–132, 1999. View at Publisher · View at Google Scholar
  36. D. J. Loegering and M. R. Lennartz, “Protein kinase C and toll-like receptor signaling,” Enzyme Research, vol. 2011, Article ID 537821, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Sudan, N. Srivastava, S. P. Pandey, S. Majumdar, and B. Saha, “Reciprocal regulation of protein kinase C isoforms results in differential cellular responsiveness,” Journal of Immunology, vol. 188, no. 5, pp. 2328–2337, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Pfeifhofer-Obermair, K. Albrecht-Schgoer, S. Peer et al., “Role of PKCtheta in macrophage-mediated immune response to Salmonella typhimurium infection in mice,” Cell Communication and Signaling, vol. 14, no. 1, p. 14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. H. Qiu and C. C. Leslie, “Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2,” The Journal of Biological Chemistry, vol. 269, no. 30, pp. 19480–19487, 1994. View at Google Scholar
  40. M. M. Monick, A. B. Carter, G. Gudmundsson, L. J. Geist, and G. W. Hunninghake, “Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes,” The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 275, no. 2, Part 1, pp. L389–L397, 1998. View at Publisher · View at Google Scholar
  41. M. Jove, A. Planavila, R. M. Sanchez, M. Merlos, J. C. Laguna, and M. Vazquez-Carrera, “Palmitate induces tumor necrosis factor-α expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-ĸB activation,” Endocrinology, vol. 147, no. 1, pp. 552–561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Jones, I. M. Adcock, B. Y. Ahmed, and N. A. Punchard, “Modulation of LPS stimulated NF-kappaB mediated nitric oxide production by PKCε and JAK2 in RAW macrophages,” Journal of Inflammation, vol. 4, no. 1, p. 23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Johnson, C. Molle, E. Aksoy, M. Goldman, S. Goriely, and F. Willems, “A conventional protein kinase C inhibitor targeting IRF-3-dependent genes differentially regulates IL-12 family members,” Molecular Immunology, vol. 48, no. 12-13, pp. 1484–1493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. P. G. Suh, J. I. Park, L. Manzoli et al., “Multiple roles of phosphoinositide-specific phospholipase C isozymes,” BMB Reports, vol. 41, no. 6, pp. 415–434, 2008. View at Publisher · View at Google Scholar
  45. L. Cocco, M. Y. Follo, L. Manzoli, and P. G. Suh, “Phosphoinositide-specific phospholipase C in health and disease,” Journal of Lipid Research, vol. 56, no. 10, pp. 1853–1860, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Di Raimo, M. Leopizzi, G. Mangino et al., “Different expression and subcellular localization of phosphoinositide-specific phospholipase C enzymes in differently polarized macrophages,” Journal of Cell Communication and Signaling, vol. 10, no. 4, pp. 283–293, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. R. A. Rebres, T. I. Roach, I. D. Fraser et al., “Synergistic Ca2+ responses by Gαi- and Gαq-coupled G-protein-coupled receptors require a single PLCβ isoform that is sensitive to both Gβγand Gαq,” The Journal of Biological Chemistry, vol. 286, no. 2, pp. 942–951, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. T. I. Roach, R. A. Rebres, I. D. Fraser et al., “Signaling and cross-talk by C5a and UDP in macrophages selectively use PLCβ3 to regulate intracellular free calcium,” The Journal of Biological Chemistry, vol. 283, no. 25, pp. 17351–17361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. R. A. Rebres, C. Moon, D. Decamp et al., “Clostridium difficile toxin B differentially affects GPCR-stimulated Ca2+ responses in macrophages: independent roles for Rho and PLA2,” Journal of Leukocyte Biology, vol. 87, no. 6, pp. 1041–1057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. C. S. Nirodi, B. C. Crews, K. R. Kozak, J. D. Morrow, and L. J. Marnett, “The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells,” Proceedings of the National Academy of Sciences of the United States of America, no. 101, pp. 1840–1845, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. S. E. Wu and W. E. Miller, “The HCMV US28 vGPCR induces potent Gαq/PLC-β signaling in monocytes leading to increased adhesion to endothelial cells,” Virology, vol. 497, pp. 233–243, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Shukla, G. Elson, P. J. Blackshear, C. S. Lutz, and S. J. Leibovich, “3UTR AU-Rich Elements (AREs) and the RNA-binding protein tristetraprolin (TTP) are not required for the LPS-mediated destabilization of phospholipase-Cβ-2 mRNA in murine macrophages,” Inflammation, vol. 40, no. 2, pp. 645–656, 2017. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Grinberg, G. Hasko, D. Wu, and S. J. Leibovich, “Suppression of PLCβ2 by endotoxin plays a role in the adenosine A2A receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype,” The American Journal of Pathology, vol. 175, no. 6, pp. 2439–2453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Spadaro, S. Cecchetti, C. Purificato et al., “Nuclear phosphoinositide-specific phospholipase C β1 controls cytoplasmic CCL2 mRNA levels in HIV-1 gp120-stimulated primary human macrophages,” PLoS One, vol. 8, no. 3, article e59705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Bezzerri, P. d'Adamo, A. Rimessi et al., “Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells,” Journal of Immunology, vol. 186, no. 8, pp. 4946–4958, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. J. I. Wilde and S. P. Watson, “Regulation of phospholipase C γ isoforms in haematopoietic cells: why one, not the other?” Cellular Signalling, vol. 13, no. 10, pp. 691–701, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Schade, C. Walliser, M. Wist et al., “Cool-temperature-mediated activation of phospholipase C-γ2 in the human hereditary disease PLAID,” Cellular Signalling, vol. 28, no. 9, pp. 1237–1251, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. B. L. Slomiany and A. Slomiany, “Mechanism of Rac1-induced amplification in gastric mucosal phospholipase Cγ2 activation in response to Helicobacter pylori: modulatory effect of ghrelin,” Inflammopharmacology, vol. 23, no. 2-3, pp. 101–109, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Piechulek, T. Rehlen, C. Walliser, P. Vatter, B. Moepps, and P. Gierschik, “Isozyme-specific stimulation of phospholipase C-γ2 by Rac GTPases,” Journal of Biological Chemistry, vol. 280, no. 47, pp. 38923–38931, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Koss, T. D. Bunney, S. Behjati, and M. Katan, “Dysfunction of phospholipase Cγ in immune disorders and cancer,” Trends in Biochemical Sciences, vol. 39, no. 12, pp. 603–611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. M. J. Kim, J. S. Chang, S. K. Park, J. I. Hwang, S. H. Ryu, and P. G. Suh, “Direct interaction of SOS1 Ras exchange protein with the SH3 domain of phospholipase C-γ1,” Biochemistry, vol. 39, no. 29, pp. 8674–8682, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Zhu, H. Ly, and Y. Liang, “PLC-γ1 signaling plays a subtype-specific role in postbinding cell entry of influenza A virus,” Journal of Virology, vol. 88, no. 1, pp. 417–424, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Carty, R. Goodbody, M. Schroder, J. Stack, P. N. Moynagh, and A. G. Bowie, “The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling,” Nature Immunology, vol. 7, no. 10, pp. 1074–1081, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Publisher · View at Google Scholar
  65. M. Yamamoto, S. Sato, H. Hemmi et al., “Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway,” Science, vol. 301, no. 5633, pp. 640–643, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Wan, T. Liu, H. Zhang, S. Tang, and W. Min, “AIP1 functions as Arf6-GAP to negatively regulate TLR4 signaling,” The Journal of Biological Chemistry, vol. 285, no. 6, pp. 3750–3757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Horng, G. M. Barton, R. A. Flavell, and R. Medzhitov, “The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors,” Nature, vol. 420, no. 6913, pp. 329–333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Yamamoto, S. Sato, H. Hemmi et al., “TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway,” Nature Immunology, vol. 4, no. 11, pp. 1144–1150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. J. C. Kagan and R. Medzhitov, “Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling,” Cell, vol. 125, no. 5, pp. 943–955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. J. C. Kagan, T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov, “TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β,” Nature Immunology, vol. 9, no. 4, pp. 361–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Y. Chiang, V. Veckman, K. Limmer, and M. David, “Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation,” The Journal of Biological Chemistry, vol. 287, no. 6, pp. 3704–3709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. I. Zanoni and F. Granucci, “Role of CD14 in host protection against infections and in metabolism regulation,” Frontiers in Cellular and Infection Microbiology, vol. 3, p. 32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Plociennikowska, M. I. Zdioruk, G. Traczyk, A. Swiatkowska, and K. Kwiatkowska, “LPS-induced clustering of CD14 triggers generation of PI(4,5)P2,” Journal of Cell Science, vol. 128, no. 22, pp. 4096–4111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. I. Zanoni, R. Ostuni, L. R. Marek et al., “CD14 controls the LPS-induced endocytosis of Toll-like receptor 4,” Cell, vol. 147, no. 4, pp. 868–880, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. X. Zhou, Y. Ye, Y. Sun et al., “Transient receptor potential channel 1 deficiency impairs host defense and proinflammatory responses to bacterial infection by regulating protein kinase Cα signaling,” Molecular and Cellular Biology, vol. 35, no. 16, pp. 2729–2739, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. S. Bae, H. Y. Lee, Y. S. Jung, M. Lee, and P. G. Suh, “Phospholipase Cγ in Toll-like receptor-mediated inflammation and innate immunity,” Advances in Biological Regulation, vol. 63, pp. 92–97, 2017. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. S. Bae, J. H. Lee, S. H. Choi et al., “Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2,” Circulation Research, vol. 104, pp. 210–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Jongstra-Bilen, A. Puig Cano, M. Hasija, H. Xiao, C. I. Smith, and M. I. Cybulsky, “Dual functions of Bruton’s tyrosine kinase and Tec kinase during Fcγ receptor-induced signaling and phagocytosis,” The Journal of Immunology, vol. 181, no. 1, pp. 288–298, 2008. View at Publisher · View at Google Scholar
  79. E. C. Larsen, J. A. DiGennaro, N. Saito et al., “Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells,” The Journal of Immunology, vol. 165, no. 5, pp. 2809–2817, 2000. View at Publisher · View at Google Scholar
  80. K. L. Cheeseman, T. Ueyama, T. M. Michaud et al., “Targeting of protein kinase C-ε during Fcγ receptor-dependent phagocytosis requires the εC1B domain and phospholipase C-γ1,” Molecular Biology of the Cell, vol. 17, no. 2, pp. 799–813, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Sun, B. Raisley, M. Langer et al., “Anti-peptidoglycan antibodies and Fcγ receptors are the key mediators of inflammation in Gram-positive sepsis,” The Journal of Immunology, vol. 189, no. 5, pp. 2423–2431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. M. J. Kim, S. Y. Rah, J. H. An, K. Kurokawa, U. H. Kim, and B. L. Lee, “Human anti-peptidoglycan-IgG-mediated opsonophagocytosis is controlled by calcium mobilization in phorbol myristate acetate-treated U937 cells,” BMB Reports, vol. 48, no. 1, pp. 36–41, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. D. Aki, Y. Minoda, H. Yoshida et al., “Peptidoglycan and lipopolysaccharide activate PLCγ2, leading to enhanced cytokine production in macrophages and dendritic cells,” Genes to Cells: Devoted to Molecular & Cellular Mechanisms, vol. 13, no. 2, pp. 199–208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. E. Szymanska, A. Sobota, E. Czurylo, and K. Kwiatkowska, “Expression of PI(4,5)P2-binding proteins lowers the PI(4,5)P2level and inhibits FcγRIIA-mediated cell spreading and phagocytosis,” European Journal of Immunology, vol. 38, no. 1, pp. 260–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Kudo, T. Uchida, M. Sawada, Y. Nakamura, A. Yoneda, and K. Fukami, “Phospholipase C δ1 in macrophages negatively regulates TLR4-induced proinflammatory cytokine production and Fcγ receptor-mediated phagocytosis,” Advances in Biological Regulation, vol. 61, pp. 68–79, 2016. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Martins, A. McCarthy, R. Baxendale et al., “Tumor suppressor role of phospholipase Cε in Ras-triggered cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 11, pp. 4239–4244, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Oldenburger, W. Timens, S. Bos et al., “Epac1 and Epac2 are differentially involved in inflammatory and remodeling processes induced by cigarette smoke,” The FASEB Journal, vol. 28, no. 11, pp. 4617–4628, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Tyutyunnykova, G. Telegeev, and A. Dubrovska, “The controversial role of phospholipase C epsilon (PLε) in cancer development and progression,” Journal of Cancer, vol. 8, no. 5, pp. 716–729, 2017. View at Publisher · View at Google Scholar · View at Scopus